 |
 |
 |
 |
|
Exofarm is a producer, importer and exporter of exotic fruit and vegetables. It was created in 1989 and merged with the Compagnie Fruitière Group in 2001. For several years now, it has been leader of its market. Its leading position is the result of a clear vision of the market, a policy of differentiation and a combination of values and commitments that the daily actions of all the company’s staff embody: customer satisfaction, innovation, quality and freshness. Exofarm responds to the most rigorous needs and requirements of its customers and to consumer expectations. Customer capital is 3an integral part of company culture. The firm’s ambition is to expand consumption of exotic fruit and vegetables in France and Europe. For Exofarm, extending this market involves a precise grasp of its developments and constant changes and the continuous ability to be both an initatiator and the driving force behind innovations, both in terms of the provision of products/origins/services and promotional resources and communication tools, in the image of our new Internet site. This proactive strategy is based on a demand for quality that is met by a well-controlled supply chain with partner producers who share the same passion, namely: very high certified quality, throughout the year. Exofarm is committed to sustainable development and makes carefully thought-out crop selections, true to its motto that “There is no such thing as healthy fruit without healthy crops”. The company has decided to conduct ethical studies of the participation in social development of populations on crop sites. The success, performance, solidity and durability of a company cannot be imagined without a profound respect for “human capital”. On this count, all of Exofarm’s staff form a closely-knit, mobilised team that is expert in its field, resourceful and receptive. The aim of one and all, in performing their duties and exercising their professions, is first and foremost customer satisfaction: this, let us not forget, is at the very heart of Exofarm’s strategy. Claude Masnada |
